Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses
2018 ◽
Vol Volume 14
◽
pp. 233-246
◽
2017 ◽
Vol 139
(5)
◽
pp. 1678-1680
◽
2016 ◽
Vol 68
(18)
◽
pp. B27-B28
Keyword(s):
2018 ◽
Vol 131
(12)
◽
pp. 1463-1472.e7
◽
2020 ◽
Vol 22
(5)
◽
pp. 834-844
◽
2014 ◽
Vol 63
(12)
◽
pp. A34
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 10068-10068
◽
2017 ◽
Vol 38
(25)
◽
pp. 1969-1977
◽
Keyword(s):